Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:55 AM
Ignite Modification Date:
2025-12-25 @ 4:55 AM
NCT ID:
NCT04245618
Eligibility Criteria:
Inclusion Criteria:
1. Patient who are older than 18 years old.
2. Histologically confirmed to have Non-muscle invasive bladder cancer, T1bN0M0 ,clinically and radiologically confirmed to have bladder cancer.
3. Patient should have Eastern Cooperative Oncology Group performances status (ECOG)0-1 with adequate hematologic, hepatic and renal functions including hemoglobin\>10 /dl, absolute neutrophil count ≥1,500/mm3, platelets ≥100,000/mm3, serum bilirubin \<2 mg/dl ,both Alanine transaminase( ALT) and aspartate aminotransferase( AST) ≤2× upper limit of normal (ULN), alkaline phosphates ≤5×ULN,and serum creatinine ≤1.5 mg/dl or creatinine clearance ≥60 ml/min.
Exclusion Criteria:
1. Patients with radiographic evidence of nodal or distant metastases.
2. A past history of upper tract disease, neuroendocrine features.
3. Non-cisplatin-based NAC .
4. Prior radiation therapy to their pelvis.
5. A palpable three-dimensional mass on EUA.
6. Known to be stage 0, T1a, II, III, IV.
7. Active serious infection, or a psychiatric illness that would preclude obtaining informed consent or history of cardiac disease will be excluded.
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT04245618
Study Brief:
Protocol Section:
NCT04245618